| The current size of global antibody products market is US $15 billion, which is predicted to cross US $ 25.7 billion by the end of 2010. The dominant market leaders of antibody products are Roche, MabThera, Genentech's Rituxan, and Johnson & Johnson's Remicade and products such as phosphatase. This industry is one of the largest growing and most lucrative sectors of biotechnology products market driven by technological advancement and growing cases of cancer, cardiovascular, infectious and other inflammable diseases. Of human antibodies, a conjugated antibody is the leading market that has shown tremendous potential in the last few years. Antibodies play a significant role in bio-pharma market as they are used therapeutically to treat life-threatening ailments.